23andMe, TMO Renewables, Biowisdom, MDL Isentris, EMBL, BioBase, Affymetrix | GenomeWeb
23andMe Completes Series A Financing; Google Holds Minority Stake
23andMe, a startup that desribes itself as a “personal genetics” company, has closed a Series A round of financing with investments from Google, Genentech, MDV-Mohr Davidow Ventures, and New Enterprise Associates. Terms of the financing were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.